872518-71-3

Basic information

• Product Name: C-(5-bromo-7-chloro-2,3-dihydro-benzofuran-2-yl)-N-BOC-methylamine
• Synonyms: C-(5-bromo-7-chloro-2,3-dihydro-benzofuran-2-yl)-N-BOC-methylamine;Carbamic acid,[(5-bromo-7-chloro-2,3-dihydro-2-benzofuranyl)methyl]-,1,1-dimethylethyl ester;Carbamic acid, [(5-bromo-7-chloro-2,3-dihydro-2-benzofuranyl)methyl]-, 1,1-dimethylethyl ester (9CI);tert-butyl ((5-bromo-7-chloro-2,3-dihydrobenzofuran-2-yl)methyl)carbamate
• CAS NO: 872518-71-3
• Molecular Formula: C₁₄H₁₇BrClNO₃
• Molecular Weight: 362.64668
• Mol File: 872518-71-3.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: C-(5-bromo-7-chloro-2,3-dihydro-benzofuran-2-yl)-N-BOC-methylamine(CAS DataBase Reference)
• NIST Chemistry Reference: C-(5-bromo-7-chloro-2,3-dihydro-benzofuran-2-yl)-N-BOC-methylamine(872518-71-3)
• EPA Substance Registry System: C-(5-bromo-7-chloro-2,3-dihydro-benzofuran-2-yl)-N-BOC-methylamine(872518-71-3)

Safety Data

• Hazardous Substances Data: 872518-71-3(Hazardous Substances Data)

Upstream product

• 90725-41-0 4-bromo-2-chloro-6-(prop-2-en-1-yl)phenol 
• 24424-99-5 di-tert-butyl dicarbonate 
• 3964-56-5 4-bromo-2-chlorophenol 
• 84109-21-7 1-(allyloxy)-4-bromo-2-chlorobenzene 
• 872518-67-7 C-(7-chloro-2,3-dihydro-benzofuran-2-yl)-N-BOC-methylamine 

Relevant articles and documents

MULTICYCLIC COMPOUNDS AND USES THEREOF

The present invention relates to multicyclic compounds containing a urea or a guanidine moiety, or pharmaceutically acceptable salts or compositions thereof represented by Structural Formula (IA) or a pharmaceutically acceptable salt thereof and pharmaceutical comopositions comprising the multicyclic compounds. The invention also relates to a method for treating a disease or disorder selected from cancer (e.g., lymphoma, such as mantle cell lymphoma), a neurodegenerative disease, an inflammatory diseases or an immune system disease (e.g., a T-Cell mediated autoimmune disesase) in a subject in need thereof. The method comprises administering to a subject in need thereof a therapeutically effective amount of a compound of the invention, or a pharmaceutically acceptable salt thereof, or a composition comprising a compound of the invention, or a pharmaceutically acceptable salt thereof.

DIHYDROBENZOFURAN COMPOUNDS AND USES THEREOF

Dihydrobenzofuran compounds of Formula (I), including salts, prodrugs, hydrates and solvates thereof, that act as 5-HT2 receptor ligands and their uses in the treatment of diseases linked to the activation of 5-HT2 receptors in anima